GoodRx Holdings (GDRX) Enterprise Value (2019 - 2025)
Historic Enterprise Value for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to -$273.5 million.
- GoodRx Holdings' Enterprise Value rose 3545.45% to -$273.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.5 million, marking a year-over-year increase of 3545.45%. This contributed to the annual value of -$448.3 million for FY2024, which is 3331.12% up from last year.
- According to the latest figures from Q3 2025, GoodRx Holdings' Enterprise Value is -$273.5 million, which was up 3545.45% from -$281.3 million recorded in Q2 2025.
- GoodRx Holdings' Enterprise Value's 5-year high stood at -$273.5 million during Q3 2025, with a 5-year trough of -$993.4 million in Q1 2021.
- In the last 5 years, GoodRx Holdings' Enterprise Value had a median value of -$730.5 million in 2022 and averaged -$662.1 million.
- In the last 5 years, GoodRx Holdings' Enterprise Value crashed by 93651.3% in 2021 and then surged by 4668.83% in 2024.
- GoodRx Holdings' Enterprise Value (Quarter) stood at -$941.1 million in 2021, then grew by 19.55% to -$757.2 million in 2022, then increased by 11.21% to -$672.3 million in 2023, then surged by 33.31% to -$448.3 million in 2024, then skyrocketed by 38.99% to -$273.5 million in 2025.
- Its Enterprise Value was -$273.5 million in Q3 2025, compared to -$281.3 million in Q2 2025 and -$301.0 million in Q1 2025.